Purpose: Mobilization is feasible, safe, and beneficial to patients admitted to critical care units. Vasoactive therapy appears to be one of the most common barriers to early mobilization. Many recent publications have studied the safety and feasibility of mobilizing patients with these vasoactive drugs. The aim of this review was to synthesize the prevailing evidence pertaining to mobilizing patients receiving vasoactive drugs. Methods: The protocol was developed and registered on PROSPERO (CRD42019127448). A comprehensive literature search was conducted using PubMed, Physiotherapy Evidence Database (PEDRO), Cochrane Central, and Embase (through Cochrane) for original research, including case studies and consensus guidelines. PRISMA guidelines were used to conduct and report this review. The included articles were appraised using the Newcastle-Ottawa Scale independently and a consensus reached by 3 reviewers. Results and Conclusion: Evidence determining specific doses of vasoactive drugs that would allow safe mobilization of patients in critical care is lacking. The criteria that have been used to determine the eligibility to mobilize patients on vasoactive drugs have not been consistent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.